MindWalk Holdings Corp. demonstrated its ReefIQ biological context layer for AI drug discovery running on AMD Instinct compute at the AMD Advancing AI 2026 event in San Francisco. The technology uses the company's proprietary HYFT technology to reconnect fragmented discovery data into a governed, queryable biological context for AI reasoning workflows. MindWalk is a Bio-Native AI company building BioIntelligence infrastructure for the life sciences industry.

MindWalk Holdings Corp. reported fiscal 2026 results with revenue increasing 46% to $15.6 million CAD and gross margin expanding to 59%. The net loss narrowed to $13.9 million CAD, compared to $30.2 million CAD in fiscal 2025, primarily due to the non-recurrence of $22.7 million in non-cash impairment charges. Key business milestones include the divestiture of its Netherlands subsidiary for $14.3 million CAD, the launch of ReefIQ in June 2026, and the signing of its first two recurring enterprise LensAI agreements. The company also regained Nasdaq compliance organically. MindWalk is a Bio-Native AI company that provides BioIntelligence infrastructure for AI drug discovery.